Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EWCZ
3676
DELISTED
European Wax Center
EWCZ
| $120K | ﹤0.01% |
12,134
-18,854
| -61% | -$214K |
|
3677
QuantumScape Corp
QS
$3.74B
| $120K | ﹤0.01% |
24,462
-55,467
| -69% | -$309K |
|
3678
MediciNova
MNOV
$66M
| $120K | ﹤0.01% |
83,200
| – | – |
|
3679
Evolv Technologies
EVLV
$1.1B
| $119K | ﹤0.01% |
46,776
-53,040
| -53% | -$176K |
|
3680
NWPX Infrastructure Inc
NWPX
$1.15B
| $118K | ﹤0.01% |
3,487
-3,491
| -50% | -$118K |
|
|
AGEN
3681
Agenus
AGEN
$290M
| $118K | ﹤0.01% |
7,036
-7,434
| -51% | -$89.8K |
|
3682
Hippo Holdings
HIPO
$861M
| $118K | ﹤0.01% |
6,856
-561
| -8% | -$10.6K |
|
3683
Lifetime Brands
LCUT
$211M
| $118K | ﹤0.01% |
13,714
+12,841
| +1,471% | +$129K |
|
3684
Ramaco Resources Class A
METC
$649M
| $118K | ﹤0.01% |
9,773
-11,803
| -55% | -$164K |
|
3685
OneWater Marine
ONEW
$201M
| $117K | ﹤0.01% |
4,261
-3,973
| -48% | -$102K |
|
3686
Taysha Gene Therapies
TSHA
$1.89B
| $117K | ﹤0.01% |
+54,234
| New | +$158K |
|
3687
Comtech Telecommunications
CMTL
$51.8M
| $117K | ﹤0.01% |
38,712
-11,044
| -22% | -$26.2K |
|
3688
Ultralife
ULBI
$106M
| $117K | ﹤0.01% |
11,040
-101
| -0.9% | -$1.07K |
|
3689
Mineralys Therapeutics
MLYS
$2.41B
| $117K | ﹤0.01% |
10,010
-3,651
| -27% | -$46K |
|
3690
Treace Medical Concepts
TMCI
$309M
| $117K | ﹤0.01% |
17,623
-23,423
| -57% | -$189K |
|
3691
iShares US Healthcare Providers ETF
IHF
$1.27B
| $117K | ﹤0.01% |
2,225
| – | – |
|
3692
Vestis
VSTS
$1.88B
| $117K | ﹤0.01% |
9,531
-33,641
| -78% | -$486K |
|
|
ACB
3693
Aurora Cannabis
ACB
$185M
| $116K | ﹤0.01% |
25,157
+1,501
| +6% | +$9.5K |
|
3694
Esquire Financial Holdings
ESQ
$1.14B
| $116K | ﹤0.01% |
2,439
-2,567
| -51% | -$121K |
|
3695
Caesarstone
CSTE
$79.5M
| $116K | ﹤0.01% |
23,174
-10,799
| -32% | -$61.2K |
|
3696
Distribution Solutions Group
DSGR
$1.61B
| $115K | ﹤0.01% |
3,848
-5,582
| -59% | -$186K |
|
3697
Camtek
CAMT
$7.25B
| $115K | ﹤0.01% |
921
-4,246
| -82% | -$405K |
|
|
MAG
3698
DELISTED
MAG Silver
MAG
| $115K | ﹤0.01% |
9,881
-8,017
| -45% | -$101K |
|
3699
Aviat Networks
AVNW
$273M
| $115K | ﹤0.01% |
4,002
-3,983
| -50% | -$126K |
|
3700
iShares Global Clean Energy ETF
ICLN
$2.4B
| $115K | ﹤0.01% |
8,604
+5,100
| +146% | +$71.4K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.